This volume reflects the changes that have taken place in the pharmaceutical industry over the last ten years, most notably the increased importance attached to the question of chirality, the growing influence of biotechnology and the need for more rigorous documentation and validation of analytical methods and procedures.
The first part of this book deals with the application of new technology to pharmaceutical and biomedical analysis, reflecting the present needs for increased speed, sensitivity and selectivity in the analysis of drugs. The second chapter provides an overview of capillary electophoresis, which represents one of the most inportant analytical developments to impact directly on pharmaceutical development in recent years. Although not a chromatographic technique, capillary electrophoresis was considered too important to be ignored.
Over the last 25 years, liquid chromatography has grown into a mature analytical technique and many of the fundamental issues concerned with retention and separation are well defined. The practitioners of modern liquid chromatography spend as much time in the development of techniques for sampling handling and automation as they do in the development of the separation. Therefore, Part Two of this book describes some of the recent advances in the areas of sample handling and the isolation of compounds from biological samples, including solid phase extraction, restricted access media for direct injection, coupled column technology and microdialysis. Similarily, Part Three contains two chapters concerned with liquid chromatographic methods for the isolation of drug substances, peptides and proteins from other complex media.
The pharmaceutical industry and the process of drug development are highly regulated and the increasing importance that the regulatory authorities attach to validation has had a significant impact on the analytical techniques used for the analysis of drugs. Although
For undergraduate pharmacy students and chemistry students; post-graduate students and faculty in analytical chemistry, pharmaceutical chemistry, pharmaceutical analysis, pharmaceutics and medicinal chemistry; and analytical scientists in government, pharmaceutical industry and biotechnology industry.
- © Pergamon 1994
- 21st October 1994
- eBook ISBN:
- Hardcover ISBN:
@from:Ram N. Gupta, Hamilton, Canada @qu:The reviews are clearly written and include references up to 1992. A number of figures of structures, chromatograms and others showing mechanistic equations have been included for clarity. There is a detailed index. Typographical errors are minimal. Print size has been selected for easy reading. The book is attractively hard bound. The development of a new drug has become quite costly. Analytical laboratories of the pharmaceutical industry are playing a very important role in keeping the cost of drug development from escalating further by providing validated assays at different stages of drug development. This book is expected to be useful to the analysis in the pharmaceutical industry. @source:Journal of Chromatography @from:Ram N. Gupta @qu:The reviews are clearly written and include references up to 1992. A number of figures of structures, chromatograms and others showing mechanistic equations have been included for clarity. There is a detailed index. Typographical errors are minimal. Print size has been selected for easy reading. The book is attractively hard bound. @source:Journal of Chromatography B: Biomedical Applications @from:Hassan Y. Aboul-Enein @qu:This book is highly recommended for analytical chemists, pharmaceuticals chemists, biochemists in both industrial and academic affiliations, and also drug regulatory centers.... This book is the start of a new series, with two more volumes to be published in the near future; I anticipate their place as valuable references in the areas of pharmaceutical and biomedical analysis @source:Journal of Liq. Chrom. & Rel. Technol.
School of Health Sciences, University of Sunderland, UK
Department of Oncology, McGill University, Montreal, Quebec, Canada
President of Riley and Rabel Consulting Services. Former Vice President of Analytical R&D at DuPont Pharmaceutical Company, and Vice President of ChemPharm at ALZA (a division of Johnson and Johnson) as well as a member of the ICH Expert Working Group on Impurities.
President of Riley and Rabel Consulting Services, Maryville, MO, USA